Ringstop Tablet
NDC Package 70163-0003-1
Package Information
Ringstop (acetylsalicylicum acidum, calcarea carbonica, carbo vegetabilis, chininum sulphuricum, cimicifuga racemosa, cinchona officinalis, coffea cruda, graphites, kali carbonicum, lycopodium clavatum, natrum salicylicum) tablets is adults and children over the age of 12 :■ take 3 tablets per day for 3-90 days, then reduce to 1 tablet twice daily. This formulation utilizes a tablet delivery system. Marketed by Naturalcare, this product is identified by NDC 70163-0003.
Identification & Billing
Clinical Specifications
- ACTIVATED CHARCOAL 8 [hp_X]/1
- ARABICA COFFEE BEAN 3 [hp_X]/1
- ASPIRIN 6 [hp_X]/1
- BLACK COHOSH 6 [hp_X]/1
- CINCHONA OFFICINALIS BARK 12 [hp_X]/1
- GRAPHITE 12 [hp_X]/1
- LYCOPODIUM CLAVATUM SPORE 12 [hp_X]/1
- OYSTER SHELL CALCIUM CARBONATE, CRUDE 8 [hp_X]/1
- POTASSIUM CARBONATE 6 [hp_X]/1
- QUININE SULFATE 12 [hp_X]/1
- SODIUM SALICYLATE 6 [hp_X]/1
- Allergens - [CS]
- Anti-Inflammatory Agents, Non-Steroidal - [CS]
- Antimalarial - [EPC] (Established Pharmacologic Class)
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Cyclooxygenase Inhibitors - [MoA] (Mechanism of Action)
- Decreased Platelet Aggregation - [PE] (Physiologic Effect)
- Decreased Prostaglandin Production - [PE] (Physiologic Effect)
- Dietary Proteins - [CS]
- Increased Histamine Release - [PE] (Physiologic Effect)
- Non-Standardized Food Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Nonsteroidal Anti-inflammatory Drug - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
- Platelet Aggregation Inhibitor - [EPC] (Established Pharmacologic Class)
- Seed Storage Proteins - [CS]
Regulatory & Marketing
Hierarchy Structure
- 70163 - Naturalcare
- 70163-0003 - Ringstop
- 70163-0003-1 - 1 BLISTER PACK in 1 CARTON / 60 TABLET in 1 BLISTER PACK
- 70163-0003 - Ringstop
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 70163-0003-1 identifies a specific commercial package of 1 blister pack in 1 carton / 60 tablet in 1 blister pack of Ringstop, a human over the counter drug labeled by Naturalcare. This tablet is formulated for oral use and contains activated charcoal; arabica coffee bean; aspirin; black cohosh; cinchona officinalis bark; graphite; lycopodium clavatum spore; oyster shell calcium carbonate, crude; potassium carbonate; quinine sulfate; sodium salicylate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Naturalcare on March 02, 2026. The current certification is valid through December 31, 2027.
How is this Naturalcare product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 70163000301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.